PHOENIX, AZ - June 7, 2017 - InvestorsHub NewsWire - NOHO, Inc.
(OTC
PINK: DRNK), a Wyoming corporation (the
"Company"), announced the following:
FDA Formulation
The Company has executed a licensing agreement with DMR
Biologics, LLC, of Schofield, Wisconsin, to acquire the exclusive
rights to market and sell its homeopathic, FDA registered drug
under the NOHO brand.
This new, lipid-based gel formulation is taken via a patented,
sublingual (under the tongue) delivery method, contained
in a small stick pack. The product offers fast and effective relief
from Hangover pain and headache in bypassing the digestive system
so it can be absorbed much faster than liquid or pill-based
formulas. As a homeopathic medicine, it has no contraindicated drug
interactions. The product's effectiveness is confirmed by two
Double-blind/Placebo controlled clinical trials. Developed as a
drug to treat migraine headaches, NOHO has contracted the exclusive
rights to the product in the Hangover market. Most Hangover
headaches are migranous in nature and there are numerous cross-over
symptoms shared between migraine headaches and Hangovers.
David Mersky, NOHO's CEO stated, "Today, we are announcing that
the company has acquired the exclusive rights to an FDA registered
medicine that will be manufactured as a new NOHO product for the
Hangover market. As an OTC drug, this new formulation will make
NOHO the market leader in the Hangover space as the product is
backed by two published clinical studies."
The company is in the process of obtaining a National Drug Code
number and has secured financing to begin production of the new
formulation within 30 days. Labeling and packaging designs will
also be underway so that all approvals will be in place when the
product is market ready in approximately 90 days. In addition to
the formulation being clinically tested with great success, it is
well-suited to both the retail and online markets, as it is small
and light (a unit dose is 3ml) and can be easily carried by users
or shipped in larger quantities at low cost.
"We are currently in negotiations for a large initial purchase
order on the new product, which we hope to close while the initial
run is in production. This new relationship will open the doors to
the retail market and provide immediate revenue to the company.
We'll be disclosing more details as we move ahead, but suffice it
to say we're really excited by what's ahead for NOHO," said
Mersky.
Greenfield Farms (GRAS)
The company, through Cherry Hill Financial, LLC, has completed
the Asset Purchase Agreement with Greenfield Farms Food Inc.
(OTC
PINK: GRAS).
Pursuant to the deal, Cherry Hill's membership interest was
acquired in exchange for 49% of GRAS' common stock. As the first of
a series of anticipated transactions, the model places NOHO in
control of the board of directors of the target.
The agreement requires GRAS to divest itself of its prior
operations and bring in a new staff of licensed brokers and support
personnel to begin marketing its pre-paid life insurance program to
employees of staffing companies throughout the country. Ronald
Heineman, GRAS' CEO will remain in place and rely on his years of
experience in the staffing industry to access nearly 24,000
employees for enrollments.
The insurance program will pair employee bases with target
companies under a co-employment relationship and offer employees
life insurance as a 401(k) alternative, providing pre-paid coverage
for up to three years.
David Mersky, NOHO, Inc.'s CEO, stated, "We have finally put all
the pieces together to complete the acquisition of GRAS so we can
begin to put the operations in place to start selling policies. It
is a highly specialized and niche insurance offering that requires
very particular components. We've got the secret sauce."
GRAS' shares will be booked corporately in NOHO's investment
account.
For additional information on NOHO please visit www.nohoshot.com and our full product site at www.imbutek.com and at www.instagram.com/nohodrink,
as well as at www.twitter.com/nohodrink
Cautionary Note Regarding Forward-Looking
Statements.
This press release contains statements that constitute
forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements
appear in a number of places in this release and include all
statements that are not statements of historical fact regarding the
intent, belief or current expectations of the Noho, Inc. (the
"Company"), its directors or its officers with respect to, among
other things: (i) financing plans; (ii) trends affecting its
financial condition or results of operations; (iii) growth
strategy and operating strategy. The words "may", "would",
"will", "expect", "estimate", "can", "believe", "potential" and
similar expressions and variations thereof are intended to identify
forward-looking statements. Investors are cautioned that any
such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, many of which are
beyond the Company's ability to control, and actual results may
differ materially from those projected in the forward
looking statements as a result of various factors. You should
not place undue reliance on forward-looking statements since they
involve known and unknown risks, uncertainties and other factors,
which are, in some cases, beyond the Company's control and which
could, and likely will, materially affect actual results, levels of
activity, performance or achievements. The Company assumes no
obligation to publicly update or revise these forward-looking
statements for any reason, or to update the reasons actual results
could differ materially from those anticipated in these
forward-looking statements, even if new information becomes
available in the future. Important factors that could cause actual
results to differ materially from the company's expectations
include, but are not limited to, those factors that are disclosed
under the heading "Risk Factors" and elsewhere in documents filed
by the company from time to time with the United States Securities
and Exchange Commission and other regulatory authorities.
Investor/Media Contact:
info@nohodrink.com
